ABSTRACT
INTRODUCTION
Wnt signaling pathways play important roles in cell development, growth, and tumorigenesis (1) (2) (3) . The cytoplasmic protein Dishevelled (Dvl/Dsh) (DVL1, DVL2, and DVL3 in mammals) is a key component of Wnt signaling pathways that relays the signals from plasma membrane-bound Wnt receptors to downstream components (4) (5) (6) (7) (8) . Dvl proteins consist of 3 highly conserved domains, the DIX (DIshevelled-aXin), PDZ (Post synaptic density-95, Disc Large and Zonular Occludens-1), and DEP (Dishevelled-EGL10-Pleckstrin) domains (9) (10) (11) (12) (13) (14) (15) (16) . The PDZ domain modulates Wnt signaling by interacting with several proteins such as 7-transmembrane Wnt receptor Frizzled (Fz) proteins (12) and the single-transmembrane receptor Tyr kinase Ryk (3, (17) (18) (19) , as well as Wnt signaling modulators such as the proteins Dapper (11) and Idax (20, 21) . The Dvl PDZ domain is approximately 100 amino acids long and consists of 6 β-strands (βA-βF) and 2 α-helices (αA-αB) (22, 23) . Although the binding mechanism of the Dvl PDZ domain and other proteins is not fully explored, we and others have reported that the Dvl PDZ domain recognizes the typical C-terminal PDZ-binding motifs or internal sequences of target proteins by using the same peptide-binding site on the surface of the Dvl PDZ domain, which is located between the αB-helix and the βB-strand structures (11, 12, 21, 24) . To identify additional peptide sequences that bind to the Dvl PDZ domain at the same peptide-binding site, we recently performed computational studies in combination with a nuclear magnetic resonance (NMR) mapping assay (25) . We showed that the VWV (Val-Trp-Val) motif is sufficient to recognize the Dvl PDZ domain. As the completion of genome sequencing projects in humans and other species have resulted in the discovery of many putative and uncharacterized proteins; we speculated that some of those proteins might have a Val-Trp-Val motif at their C termini and regulate the Wnt signaling pathways by binding Dvl proteins.
Here we identified Dvl-binding molecules by combining bioinformatics, biophysics, and biochemistry approaches. In addition, microarray data deposited in a public database were analyzed to identify any correlation between the expression of the target Tmem88 gene and that of genes involved in Wnt signaling. As databases of gene expression profiles have recently increased dramatically in number and scope (26) ; we believe that a comprehensive analysis of microarray databases further facilitated the assessment of the function of a targeted gene.
Here we report that the transmembrane protein 88 (TMEM88) interacts with the cytoplasmic Dvl protein through the PDZ domain and can attenuate Wnt/β-catenin signaling induced by the Wnt-1 ligand. The analysis of Gene Expression Omnibus (GEO) data (26) from 3 different tissues revealed that the expression of the TMEM88 gene correlates with that of components of the Wnt pathways, suggesting that TMEM88 binds Dvl to modulate Wnt signaling.
EXPERIMENTAL PROCEDURES
Database Searches--Using the ScanProsite database (http://ca.expasy.org/tools/scanprosite), we searched for proteins containing a Val-Trp-Val motif at the C terminus in invertebrates and vertebrates (27) Cell Culture, Transfection, and the Luciferase Assay-Most experimental methods used have been described previously (13) . In brief, the full cDNA clone of human TMEM88 (clone ID: IOH29129) was purchased from Invitrogen. The expression of Wnt-1 and TMEM88 was driven by a cytomegalovirus promoter. HEK293 cells were maintained in 24-well plates. Cells in each well were co-transfected with 0.01 μg Lef-1 expression plasmid, 0.075 μg Lef-1 luciferase reporter plasmid, 0.05 μg green fluorescent protein (GFP) expression plasmid, 0.003 μg Wnt-1 expression plasmid, and various amounts of TMEM88. Cells were transfected without Wnt-1 expression plasmid as basal control. Additional LacZ plasmid was added to to equilibrate the total amount of DNA to 0.25 μg per transfection. After 1 day of growth, the cells were lysed, and GFP levels was measured by using a Wallac multicounter and luciferase activity levels were measured by the Kit (Luciferase Reporter Gene Assay, high sensitivity, Roche) according to the manufactory's manual. ; the luciferase activity was normalized against the levels of GFP expression. Each experiment was carried out in duplicate, and the standard deviation was calculated.
TMEM88 knockdown experiment -HEK293T cells were seeded in 24-well plate. 24 hrs later, cells in each well were transfected with 0.19 μg TOPflash, 0.01ug GFP and 0.14 μg TMEM88 RNAi (Cat # TMEM88-HSS190049 from Invitrogen) by using lipofectamine 2000 according to manufactory's protocol. For the control, cells in each well were transfected with 0.19 μg TOPflash (TCF Reporter Plasmid), 0.01 μg GFP and 0.14 μg lacZ. 66 hrs after transfection, cell culture medium were replaced by DMEM. After 6 hrs cultured in DMEM, cells were lysed and subject to GFP and luciferase measurement according previously described method (29) .
Xenopus Embryo Studies-Xenopus eggs were obtained from female frogs that had been injected with 500 IU of human chorionic gonadotropin (Sigma-Aldrich) and artificially fertilized. Synthesis and microinjection of mRNAs were carried out as described before (30, 31) .
To investigate the subcellular distribution of TMEM88, we generated a fusion of the mycepitope to the N-terminal region of TMEM88, myc-tagged TMEM88, and injected the myctagged mRNA into the animal pole region of Xenopus embryos at the 4-cell stage. Animal cap explants were dissected at the late blastula stage and fixed. Immunofluorescent staining was performed using an anti-myc antibody and a FITC-conjugated secondary antibody. In addition, the effect of TMEM88 on the subcellular distribution of the GFP-tagged XDsh (Dsh-GFP) in Xenopus was examined. Dsh-GFP mRNA was injected alone or co-injected with mRNA of human TMEM88 or TMEM88-ΔC that lacks PDZ-binding motif at the last C-terminal tail into animal blastomerase at the 4-8 cell stage. GFP fluorescence was assessed in animal explants. Localization of myc-TMEM88 or Dsh-GFP protein in Xenopus was examined by fluorescence confocal microscopy.
For the luciferase assay, the Siamois promoter-driven reporter DNA construct (Sialuc, 400 pg) (12, 31, 32) was injected alone or coinjected with mRNAs of Xdsh, β-catenin, and myc-tagged TMEM88 (100 pg each) into the animal pole region of Xenopus embryos at the 2-cell stage. Injected embryos were cultured and animal cap explants were dissected at the lateblastula stage and luciferase assays (Promega) were performed by preparing cell lysates from 10 explants and measuring luciferase activity in a Lumat LB 9507 luminometer. For the secondary axis assay, Xdsh mRNA (500 pg) or Xdsh mRNA (500 pg) together with myc-tagged TMEM88 (500 pg) were injected into the ventrovegetal region of embryos at the 4-cell stage, and injected embryos were then cultured until they reached the larval stage.
Analysis of GEO Profiling-Three microarray data sets were selected from GEO that had high TMEM88 expression, replicates, and were performed on current Affymetrix GeneChip Mouse Genome 430 2.0 arrays (26) . To stabilize variance, the MAS 5.0 signal was natural log-start transformed by the following formula: ln(MAS 5.0 signal + 20). The transformed expression of each probe set on the array was linearly correlated with the transformed signal of TMEM88 by using Pearson's coefficient (rho) using a script written for STATA 10.1 software (College Station, TX) for each of the experiments. In brief, a correlation sums the gene expression differences between any 2 genes, across multiple arrays, and then divides that sum by the total number of array experiments examined to give the Pearson's rho. Rho (ρ) values, which measure the degree of association between variables, range from -1 to 1.
RESULTS

Identification of Proteins that Have a ValTrp-Val
Motif at the C-terminal Tail -The Dvl PDZ domain recognizes the Val-Trp-Val tripeptide (25) ; thus, we hypothesized that by interacting with the Dvl PDZ domain, some of the proteins containing the motif at the C terminus would be novel Wnt-signaling modulators. We, therefore, searched the ScanProsite database for such proteins and identified 294 proteins from invertebrates and vertebrates (protein fragments were excluded, data not shown). Among these proteins, six are human proteins (Table 1) . To ascertain possible binding partners, we searched for data about these proteins on the protein-protein interaction databases (33) (34) (35) , but the results were negative. We then used the online database Ensemble to examine the expression patterns and subcellular localizations of the 5 proteins (Table  1) . Because the human DVL proteins are located in the cytoplasm, ubiquitously expressed in fetal and adult tissues, and not secreted (10,36), we focused on TMEM88, a transmembrane protein, as the most likely binding partner of the Dvl PDZ domain. TMEM88 is a 2-transmembrane-type protein; residues 44 through 66 comprise the first TM domain, and residues 86 through 108 comprise the second (Fig. 1A) . Additional database searches revealed that, in humans, TMEM88 (Q6PEY1) is expressed in placenta (28.8%), embryonic tissue (10.02%), spleen (9.66%), muscle (8.48%), heart (6.64%), bone (6.50%), eye (5.65%), kidney (4.75%), and other tissues (4.67%). (http://harvester.embl.de/harvester/Q6PE/Q6PEY1 .htm). TMEM88 is also well conserved in mammals (Fig. 1B and C) . Furthermore, ensemble database-mining showed that TMEM88 (Q9D0N8) is expressed throughout the mouse embryo (data not shown).
Direct Interaction between the C Terminus of TMEM88 and the Dvl PDZ Domain-
Although the Val-Trp-Val tripeptide is bound to the Dvl PDZ domain (25) , interactions with other upstream amino acid residues at the C terminus of TMEM88 may be important to regulate the interaction of the Dvl PDZ domain. Therefore, we characterized the interaction between the Dvl PDZ domain and a 13-mer peptide from the C terminus of human TMEM88 (TMEM88C) by performing NMR-titration experiments in which the 1 H, 15 N-HSQC spectra of the uniformly 15 N-labeled PDZ domain of Dvl were recorded while unlabeled TMEM88C was gradually added ( Fig. 2A) (37) . (Fig. 2B) . The normalized chemical-shift changes (Δδ binding ) for each backbone amide are shown in Figure 2C . In addition, the backbone worm structure of the Dvl-1 PDZ domain was generated to show the effect of binding the TMEM88C peptide (Fig. 2D ) and indicated that TMEM88C binds to the conventional peptide-binding groove between the αB-helix and βB-sheet structures in the PDZ domain of Dvl-1 as expected. We observed little difference in the chemical-shift perturbations of the Val-Trp-Val tripeptide and TMEM88C caused by binding to the Dvl PDZ domain (25) . The difference of Δδ binding (ΔΔδ binding ) of the Dvl-1 PDZ domain for the 2 bound peptides was less than 0.03, indicating that the last 3 residues at the extreme C terminus of TMEM88 would be crucial to determine the binding.
To (Fig. 2E) . As predicted by results from the NMR experiments, the binding affinity of TMEM88C (K D = 2.0 ± 0.2μM) and that of the tripeptide Val-Trp-Val (K D = 1.9 ± 0.3μM) to the Dvl-1 PDZ domain were comparable.
TMEM88 Attenuates Wnt1-ligand-induced Signaling-Because TMEM88 binds to the Dvl PDZ domain in vitro, we examined its effect on Wnt/β-catenin signaling. Because a direct interaction of the Dvl PDZ domain with the internal sequence of Fz protein is essential to activate Wnt signaling (12, 16, 38) , we reasoned that if TMEM88 binds to the Dvl PDZ domain in cells, then overexpressing TMEM88 might disrupt the Dvl-Fz interaction at the plasma membrane region, which, in turn, would suppress Wnt/β-catenin signaling. To test this hypothesis, we employed a luciferase-based cell assay (29) . In HEK293 cells transfected with Wnt-1 plasmid, canonical Wnt signaling was activated, indicated by increased luciferase activity (Fig. 3) (13) . When TMEM88 was co-expressed with Wnt-1 in the cells, Wnt-1-induced activation of luciferase was attenuated (Fig. 3) . The increased amount of TMEM88 expression plasmid resulted in the substantial attenuation of Wnt-1-induced luciferase activity, indicating that TMEM88 protein blocks Wnt signaling, presumably by disrupting the Dvl-Fz interaction in cells. To confirm this result, we performed the same experiment with TMEM88-ΔC4, which lacks 4 amino acid residues at the extreme C terminus (Fig.  3) . The loss of the PDZ-binding motif of TMEM88 causes little inhibitory effect on Wnt-1-induced signaling in a dose-dependent manner, indicating that the binding of TMEM88 to the Dvl-1 PDZ domain is essential to block Wnt signaling.
Knockdown of TMEM88 increases the Wnt activity -Since TMEM88 is expressed in kidney and can inhibit the Wnt-1-induced signaling in HEK293 cells, we used RNAi to suppress the endogenous expression of TMEM88 in HEK293 cells to investigate the effect of TMEM88 knockdown on Wnt activity.
By using the luciferase report assay (29), we found that, comparing to the control, the Wnt activity was increased more than 2 folds in the TMEM88 suppressed cells (Fig. 4) , indicating that endogenous TMEM88 inhibits the canonical Wnt signaling in HEK293 cells.
Subcellular Localization of TMEM88 Protein and its Effect on Wnt signaling in Xenopus
-Because TMEM88 was predicted to be a membrane protein, we decided to investigate the subcellular distribution of TMEM88 in a Xenopus embryo system. We first generated a fusion of the myc-epitope to the N-terminal region of TMEM88, myc-tagged TMEM88, and injected the mRNA of myc-tagged into the animal pole region of Xenopus embryos at the 4-cell stage. Animal cap explants were dissected at the late blastula stage and fixed. Then, immunofluorescent stainings were performed and localization of myc-TMEM88 protein in Xenopus was examined by fluorescence confocal microscopy. As showed in Figure 5 , myc-TMEM88 proteins were essentially localized to the cell membrane, indeed, TMEM88 is a membrane protein.
We then examined the effect of TMEM88 on the subcellular distribution of XDsh-GFP in Xenopus. XDsh-GFP mRNA was injected alone or co-injected with TMEM88 mRNA into animal blastomerase at the 4-8 cell stages. XDsh-GFP was found in a punctuate, cytoplasm distribution in animal cap cells (Fig. 6A) (39) . Co-injection of TMEM88 led to the recruitment of XDsh-GFP to the cell membrane (Fig. 6B) . Remarkably, TMEM88-ΔC that lacks the PDZ binding motif at the C-terminus failed to recruit XDsh-GFP to the cell membrane (Fig. 6C) . Together, the data suggest that TMEM88 binds to Dvl protein through its last C-terminus residues and the binding recruits Dvl to the membrane.
To assess the role of TMEM88 in the Wnt signaling in vivo, we used a previously established luciferase assay (12, 31, 32) . Xenopus Wnt target gene siamois promoter-driven luciferase reporter construct was injected alone or co-injected with synthetic Xdsh mRNA, Xdsh mRNA together with myc-tagged TMEM88 mRNA, β-catenin mRNA, and β-catenin mRNA plus myc-tagged TMEM88 mRNA respectively in the animal pole region at the at the two cell stage (31) . Injected embryos were cultured and animal cap explants were dissected at the late-blastula stage and luciferase assays (Promega) were performed by preparing cell lysates from 10 explants and measuring luciferase activity in a Lumat LB 9507 luminometer. Consistent with the results in the cell assay, TMEM88 inhibited Siamois promoterdriven luciferase activity induced by Xdsh but not by β-catenin (Fig. 7A) . This result indicates that TMEM88 inhibits canonical Wnt signaling at the level of Xdsh.
To further examine the role of TMEM88, we also employed the Xenopus secondary axis assay (12) . As showed in Fig. 7B TMEM88 Gene Expression Profile-Given that TMEM88 suppresses Wnt-1-induced β-catenin signaling in cells and in Xenopus embryos, we wondered whether the expression of the TMEM88 gene is correlated with that of other genes involved in Wnt signaling. To determine this, we reanalyzed the TMEM88 gene expression profile on the GEO database (26) . We downloaded raw data from three embryonic mouse tissues: cardiac (GEO number: GSE1479), colon (GEO number: GSE5261), and small intestines (GEO number: GSE6383) and examined the Pearson correlations of TMEM88 with the upstream components of Wnt signaling.
We detected strong Pearson correlations of TMEM88 expression with that of several Wnt signaling-related genes in the embryonic small intestines: Fzd1 (ρ= 1.00), Fzd2 (ρ = 1.00), Fzd7 (ρ = 0.86), Fzd9 (ρ = 0.90), Frzb (ρ = 0.89), Dvl1 (ρ = 0.82), Dvl2 (ρ = 0.89), and Dvl3 (ρ = 0.92) (Table S1 ). We also observed modest Pearson correlations between the expression of TMEM88 and that of the following Wnt signaling-related genes in other tissues: in embryonic mouse cardiac tissue, ROR1 (ρ = 0.61); and in the colon, Fzd1 (ρ = -0.67), Fzd2 (ρ = −0.49), and Frzb (ρ = −0.63) ( Table 2 ). These results suggest that TMEM88 conditionally modulates Wnt signaling-related gene expression.
DISCUSSION
During the course of this work, Stiffler et al. suggested that TMEM88 protein might be a Dvl3 PDZ-binding candidate (40) . In this report, we demonstrate that TMEM88 is a novel Dvl-1-binding protein that modulates Wnt signaling. The chemical-shift perturbations of 15 N-labeled PDZ domain of Dvl-1 show that the C terminus of TMEM88 occupies the binding groove of the Dvl-1 PDZ domain, as do the known Dvl PDZ-binding partners Fz and Dapper (12, 25, 41) . The binding affinity of TMEM88C to the Dvl-1 PDZ domain obtained by analyzing fluorescence data is similar to that of known Dvl PDZ-binding partners (12, 25, 41) suggesting that TMEM88 may compete with known Dvl-binding partners.
Sequence analysis suggested that TNEM88 has two trans-membrane domains and our studies in Consistent In Xenopus confirmed that TMEM88 is a membrane protein. We showed that the interaction between TMEM88 and Dvl protein could recruit Dvl to the membrane.
Both the cell-based and Xenopus assays showed that TMEM88 disrupts canonical Wnt signaling. During canonical Wnt/β-catenin signaling, the Wnt ligand binds to its coreceptors, Fz and LRP5/6 (a single-span transmembrane LDL receptor-related protein 5/6), resulting in the activation of the cytoplasmic Dvl proteins (7). The activated Dvl proteins then relay the Wnt signals to the downstream components (5). Moreover, we previously reported that the protein-protein interaction between the membrane-bound Fz receptor and the PDZ domain of Dvl plays a role in conveying Wnt signals downstream (12, 22) . Therefore, the attenuation of Wnt-1-induced signaling by TMEM88 implies that the C-terminal region of TMEM88 locates in the cytoplasmic region and binds to the Dvl PDZ domain, which leads to the disruption of the Fz-LRP5/6-Dvl complex, thus affecting canonical Wnt signaling. Consistent with this hypothesis, TMEM88 knockdown in HEK293 cells increased the Wnt activity. Additionally, the reanalysis of microarray data provided evidence that the expression of TMEM88 was closely associated with the genes involved in Wnt signaling in embryonic mouse intestines.
The Dvl proteins are key players in Wntsignaling pathways, and more than 20 binding partners of these proteins have been reported (4, 5) . For example, Dapper, Idax, and Naked cuticle inhibit canonical Wnt signaling by binding to Dvl proteins (4, 5, 11, 20) ; however, Ryk and Diversin function in the noncanonical Wnt-signaling pathway by interacting with Dvl (18, 42) . Because Dvl protein-protein interactions regulate a variety of biological processes (5, 43) , identifying novel Dvl-binding partners is of great importance. This study is a good example of how a combinatorial approach can be broadly applied to reduce the number of candidate proteins when searching for novel Dvl-binding partners.
Finally, TMEM88 may play an important role in diseases, including cancers. Human TMEM88 gene is mapped to chromosome 17p13.1, from position 7,699,108 to 7,700,142 (Ensemble database) (Fig. S1) . Several studies have shown that the loss of heterozygosity at 17p13.1 appears to be associated with an adverse disease course (44) (45) (46) (47) (48) . Although most of these analyses addressed the role of TP53, further study of TMEM88 may be interesting because the 2 genes between TP53 and TMEM88 are separated by only about 200 kb. Wnt-1 expression plasmid, and various amounts of either TMEM88 (blank boxes) or TMEM88-ΔC4 (light gray boxes). As controls (Ctl), the cells were transfected with the same preparation in the absence of the Wnt-1 expression plasmid. The LacZ plasmid was added to equilibrate the total amount of 0.25ug DNA per transfection. After 1 day of growth, the cells were lysed, and GFP levels and luciferase activities were determined. Each experiment was carried out in duplicate, and error bars represent the standard deviation. Figure 4 . TMEM88 knockdown increases the Wnt activity. HEK293T cells were seeded in 24-well plate. 24 hrs later, cells in each well were transfected with 0.19 μg topflash, 0.01ug GFP and 0.14 μg TMEM88 RNAi by using lipofectamine 2000. For the control, cells in each well were transfected with 0.19 μg topflash, 0.01 μg GFP and 0.14 μg lacZ. 66 hrs after transfection, cell culture medium were replaced by DMEM. After 6 hrs cultured in DMEM, cells were lysed and subject to GFP and luciferase measurement. The luciferase activity was increased about 2 times by knockdown of TMEM88 by RNAi. the animal pole region of 4-cell-stage Xenopus embryos, and ectodermal explants were dissected at the late-blastula stage for a luciferase activity assay. Luciferase activity induced by Xdsh was examined. TMEM88 inhibits canonical Wnt signaling induced by Xdsh but not by β-catenin, indicating that TMEM88 blocks the signaling at the level of Xdsh. (b,c) Summary of the effect of TMEM88 on the formation of the secondary axis induced by Xdsh. TMEM88 efficiently blocks the formation of the secondary axis induced by Xdsh in Xenopus embryos. MADVPGAQRPVPGGGPEPRDPLDCWACAVLVTAQNLLVAAFNLLLLALVLGTILLPAVTM 60 **:**.***. ...************************.******.*********** * hTMEM88
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